RS51029B - Upotreba antagonista bradikinin-b2 receptora za lečenje osteoartroze - Google Patents
Upotreba antagonista bradikinin-b2 receptora za lečenje osteoartrozeInfo
- Publication number
- RS51029B RS51029B YUP-2005/0565A YUP20050565A RS51029B RS 51029 B RS51029 B RS 51029B YU P20050565 A YUP20050565 A YU P20050565A RS 51029 B RS51029 B RS 51029B
- Authority
- RS
- Serbia
- Prior art keywords
- arg
- pro
- tic
- oic
- gly
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/043—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Upotreba jedinjenja formule I(I) A-B-X-E-F-K-(D)-TIC-GM-M-F'-I odabranog iz grupe:H-(D)-Arg-Arg-Pro-Hyp-Gly-Thia-Ser-(D)-Tic-Oic-Arg-OH, H-(D)-Arg-Arg-Pro-Pro-Gly-Thia-Ser-(D)-Tic-Oic-Arg-OH, H-(D)-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-(D)-Tic-Oic-Arg-OH, H-(D)-Arg-Arg-Hyp-Pro-Gly-Phe-Ser-(D)-Tic-Oic-Arg-OH i H-(D)-Arg-Arg-Pro-Pro-Gly-Phe-Ser-(D)-Tic-Oic-Arg-OHza proizvodnju leka za profilaksu i terapiju osteoartroze, spondiloze, hondroporoze posle traume zgloba ili relativno dugotrajne imobilizacije zgloba posle povrede meniskusa ili patele ili povrede ligamenata.Prijava sadrži još 2 zavisna patentna zahteva.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MEP-410/08A MEP41008A (en) | 2003-02-07 | 2004-01-23 | Use of bradykinin-b2 receptor antagonists for treating osteoarthrosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10304994A DE10304994A1 (de) | 2003-02-07 | 2003-02-07 | Die Verwendung von Antagonisten des Bradykinin-B2 Rezeptors zur Behandlung von Osteoarthrose |
PCT/EP2004/000550 WO2004069266A2 (de) | 2003-02-07 | 2004-01-23 | Die verwendung von antagonisten des bradykinin-b2 rezeptors zur behandlung von osteoarthrose |
Publications (2)
Publication Number | Publication Date |
---|---|
RS20050565A RS20050565A (en) | 2007-09-21 |
RS51029B true RS51029B (sr) | 2010-10-31 |
Family
ID=32797325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2005/0565A RS51029B (sr) | 2003-02-07 | 2004-01-23 | Upotreba antagonista bradikinin-b2 receptora za lečenje osteoartroze |
Country Status (31)
Country | Link |
---|---|
EP (1) | EP1594520B1 (sr) |
JP (1) | JP2006516980A (sr) |
KR (1) | KR20050105447A (sr) |
CN (1) | CN1317029C (sr) |
AR (1) | AR043036A1 (sr) |
AT (1) | ATE335500T1 (sr) |
AU (1) | AU2004210396A1 (sr) |
BR (1) | BRPI0407333A (sr) |
CA (1) | CA2514152C (sr) |
CO (1) | CO5690613A2 (sr) |
CY (1) | CY1105708T1 (sr) |
DE (2) | DE10304994A1 (sr) |
DK (1) | DK1594520T3 (sr) |
ES (1) | ES2268622T3 (sr) |
HK (1) | HK1085926A1 (sr) |
HR (1) | HRP20050701B1 (sr) |
IL (1) | IL169899A0 (sr) |
MA (1) | MA27618A1 (sr) |
ME (1) | MEP41008A (sr) |
MX (1) | MXPA05007310A (sr) |
MY (1) | MY135827A (sr) |
NO (1) | NO333903B1 (sr) |
NZ (1) | NZ541680A (sr) |
PE (1) | PE20040939A1 (sr) |
PL (1) | PL206412B1 (sr) |
PT (1) | PT1594520E (sr) |
RS (1) | RS51029B (sr) |
RU (1) | RU2329057C2 (sr) |
TW (1) | TW200505472A (sr) |
WO (1) | WO2004069266A2 (sr) |
ZA (1) | ZA200505177B (sr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0710522D0 (en) * | 2007-06-01 | 2007-07-11 | Royal Veterinary College The | Drug delivery system comprising matrix metalloproteinase inhibitors |
IT1391236B1 (it) | 2008-07-11 | 2011-12-01 | St Luso Farm D'italia Spa | Composizioni farmaceutiche a base di antagonisti del recettore b2 delle chinine e corticosteroidi e loro uso |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE63490B1 (en) * | 1988-11-24 | 1995-05-03 | Hoechst Ag | Peptides having bradykinin antagonist action |
MX9100717A (es) * | 1990-08-24 | 1992-04-01 | Syntex Inc | Antagonistas de la bradiquinina |
FR2751650B1 (fr) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
CA2364178C (en) * | 2000-12-05 | 2006-01-10 | Yasuhiro Katsu | N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
AU2003212898B2 (en) * | 2002-02-01 | 2008-10-02 | Omeros Corporation | Compositions and methods for systemic inhibition of cartilage degradation |
-
2003
- 2003-02-07 DE DE10304994A patent/DE10304994A1/de not_active Withdrawn
-
2004
- 2004-01-13 PE PE2004000064A patent/PE20040939A1/es not_active Application Discontinuation
- 2004-01-23 WO PCT/EP2004/000550 patent/WO2004069266A2/de active IP Right Grant
- 2004-01-23 AU AU2004210396A patent/AU2004210396A1/en not_active Abandoned
- 2004-01-23 ME MEP-410/08A patent/MEP41008A/xx unknown
- 2004-01-23 KR KR1020057014116A patent/KR20050105447A/ko not_active Application Discontinuation
- 2004-01-23 PL PL376605A patent/PL206412B1/pl unknown
- 2004-01-23 AT AT04704552T patent/ATE335500T1/de active
- 2004-01-23 EP EP04704552A patent/EP1594520B1/de not_active Expired - Lifetime
- 2004-01-23 ES ES04704552T patent/ES2268622T3/es not_active Expired - Lifetime
- 2004-01-23 NZ NZ541680A patent/NZ541680A/en not_active IP Right Cessation
- 2004-01-23 CA CA2514152A patent/CA2514152C/en not_active Expired - Fee Related
- 2004-01-23 CN CNB2004800034498A patent/CN1317029C/zh not_active Expired - Fee Related
- 2004-01-23 PT PT04704552T patent/PT1594520E/pt unknown
- 2004-01-23 DK DK04704552T patent/DK1594520T3/da active
- 2004-01-23 MX MXPA05007310A patent/MXPA05007310A/es active IP Right Grant
- 2004-01-23 DE DE502004001159T patent/DE502004001159D1/de not_active Expired - Lifetime
- 2004-01-23 RS YUP-2005/0565A patent/RS51029B/sr unknown
- 2004-01-23 RU RU2005127862/15A patent/RU2329057C2/ru not_active IP Right Cessation
- 2004-01-23 JP JP2006501585A patent/JP2006516980A/ja active Pending
- 2004-01-23 BR BR0407333-9A patent/BRPI0407333A/pt not_active IP Right Cessation
- 2004-02-05 TW TW093102562A patent/TW200505472A/zh unknown
- 2004-02-05 AR ARP040100363A patent/AR043036A1/es unknown
- 2004-02-06 MY MYPI20040362A patent/MY135827A/en unknown
-
2005
- 2005-06-27 ZA ZA200505177A patent/ZA200505177B/en unknown
- 2005-07-26 IL IL169899A patent/IL169899A0/en unknown
- 2005-08-03 CO CO05076615A patent/CO5690613A2/es not_active Application Discontinuation
- 2005-08-04 HR HRP20050701AA patent/HRP20050701B1/hr not_active IP Right Cessation
- 2005-08-05 MA MA28425A patent/MA27618A1/fr unknown
- 2005-09-06 NO NO20054144A patent/NO333903B1/no not_active IP Right Cessation
-
2006
- 2006-05-25 HK HK06106009A patent/HK1085926A1/xx not_active IP Right Cessation
- 2006-10-16 CY CY20061101482T patent/CY1105708T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0312957A (pt) | Composto ou um sal farmaceuticamente aceitável deste, uso do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, em necessidade de tal tratamento | |
BRPI0412219A (pt) | composto, sal farmaceuticamente aceitável de um composto, composição farmacêutica, método para regular a transdução de sinal método para tratamento ou prevenção de uma doença | |
BR0207526A (pt) | Composto, composição farmacêutica, e, métodos para o tratamento da dor, da enxaqueca, depressão, ansiedade, esquizofrenia, doença de parkinson ou derrame cerebral | |
BRPI0007487B8 (pt) | difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase | |
NZ592425A (en) | Isoindoline compounds for use in the treatment of cancer | |
BRPI0418181A (pt) | emprego de 2-aminotetralinas substituìdas para prevenção do tratamento de morbus parkinson | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
AU2804400A (en) | Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists | |
WO2005072308A3 (en) | Cgrp receptor antagonists | |
BRPI0508051A (pt) | derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes | |
BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
EA200700099A1 (ru) | Производные пиридина | |
BRPI0113162B8 (pt) | compostos ariloxialquilaminas nao-imidazólicos e composição farmacêutica compreendendo os referidos compostos | |
HRP20050103B1 (hr) | N-aril supstituirani bifenilkarboksamidi kao inhibitori sekrecije apolipoproteina b | |
EA200500286A1 (ru) | Новые изотиазольные и изоксазольные соединения в качестве ингибиторов трансформирующего фактора роста (тфр) | |
EA200500377A1 (ru) | Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf) | |
MA27991A1 (fr) | Derives d'aminoquinoline et leur utilisation comme ligands d'adenosine a3 | |
RS51069B (sr) | Upotreba oksikodona za tretiranje visceralnog bola | |
BR0305708A (pt) | Derivados de benzimidazol para o tratamento de disfunção sexual | |
SE0301320D0 (sv) | Positive modulators of nicotinic acetylcholine receptors | |
BR0205812A (pt) | Benzimidazois úteis no tratamento da disfunção sexual | |
BR0309757A (pt) | 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases | |
TW200519101A (en) | Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors | |
CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων |